Immune to Cancer: The CRI Blog
-
How CRI is Standing Firm in the Face of Federal Funding Cuts
Recent reporting in The New York Times describes deep uncertainty across America’s cancer research ecosystem: stalled grant… -
Celebrating Changemakers in Cancer Immunotherapy at CRI’s 2025 Annual Awards Gala
The Cancer Research Institute (CRI) hosted its 2025 Annual Awards Gala on Tuesday, October 21, at the… -
Remembering Dr. Malcolm A.S. Moore, A Visionary Who Helped Change the Course of Cancer Treatment
The Cancer Research Institute (CRI) mourns the loss of Malcolm A.S. Moore, DPhil, who passed on September… -
Introducing IGNITE: A Bold Pathway to Independence for Emerging Scientists
In every generation, progress in science depends on more than ideas—it depends on bold and brave leaders…. -
Approval Alert: A Faster, Easier, and Patient-Centered Way to Receive Immunotherapy
In another significant step toward making cancer treatment more convenient and accessible for patients, the U.S. Food… -
CICON25 Reveals Bold New Strategies to Make Cancer Immunotherapy More Effective
The Ninth International Cancer Immunotherapy Conference (CICON25) wrapped up on September 12 in Utrecht, The Netherlands with… -
Childhood Cancer: Types, Treatments, and the Future of Research
A cancer diagnosis is always extremely difficult news for a patient and their family. It can be… -
Dan McMahon’s Legacy: Inspiring Research in Esophageal Cancer
Daniel James McMahon was many things to many people. Most knew him as a prolific musician and… -
A Timeline of Cancer Immunotherapy: How CRI Helped Rewrite Treatment
Cancer immunotherapy didn’t just emerge—it was built, brick by brick—by pioneers who believed the immune system could…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.